Drugmaker Teva hires Lundbeck CEO Schultz to restore its health

JERUSALEM/COPENHAGEN (Reuters) - Teva poached Lundbeck's Kare Schultz as its new chief executive on Monday, handing the drugs industry veteran the urgent task of convincing investors of the struggling Israeli firm's future.